[Induction of bradykinin B1 receptor in rats].
We found the time-dependent induction of the systemic hypotensive response to des-Arg9-bradykinin and the contractile response of ileum of rats to des-Arg9-bradykinin. Both induced responses to des-Arg9-bradykinin were inhibited by treatment with a B1 receptor competitive antagonist, while the responses to bradykinin was constant throughout the experiment and was not influenced by the B1 antagonist, suggesting that these responses occur via a B1 receptor. The potencies of des-Arg9-bradykinin in these responses were comparable to those of bradykinin at a molar base. The other characteristics of this phenomenon is that several hours were required to the induction of these responses. In a case of hypotensive response, intravenous LPS pretreatment was necessary, but not for the induction of contraction in ileum preparation. Treatment with actinomycin D or cycloheximide throughout the experiment suppressed the induction of the contractile response to des-Arg9-bradykinin. The expression of B1 receptor gene was also confirmed by a RT-PCR method. Therefore, we concluded that these responses to des-Arg9-bradykinin occurred via a B1 receptor, which could be newly generated time-dependently.
Ueno
A
A
Department of Pharmacology, Kitasato University School of Pharmaceutical Sciences, Tokyo, Japan.
Oh-ishi
S
S
D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives / Q000494:pharmacology; D007022:Hypotension / Q000139:chemically induced; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000502:physiology; D013997:Time Factors
D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; C024626:bradykinin, des-Arg(9)-; D001920:Bradykinin